Results 231 to 240 of about 17,333,893 (364)
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts+8 more
wiley +1 more source
A causal framework for the drivers of animal social network structure. [PDF]
Kawam B+4 more
europepmc +1 more source
WHAT GRAPHICAL AND STATISTICAL MATERIAL SHOULD BE INCLUDED IN THE NINTH‐GRADE MATHEMATICS COURSE?1 [PDF]
L. E. Mensenkamp
openalex +1 more source
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira+14 more
wiley +1 more source
Statistical Methods in Research.
Frederick Mosteller, Palmer O. Johnson
openalex +2 more sources
STATISTICAL NOTE ON THE DATA RELATING TO NITROGEN CONTENT AND VALUATION [PDF]
R. A. Fisher
openalex +1 more source
Statistical significance for genomewide studies
John D. Storey, R. Tibshirani
semanticscholar +1 more source
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga+8 more
wiley +1 more source
Effective Statistics Are Essential for Strengthening a Paper in Brain and Behavior. [PDF]
Ordak M, Bosurgi R.
europepmc +1 more source